Page last updated: 2024-10-31

mitotane and Retroperitoneal Neoplasms

mitotane has been researched along with Retroperitoneal Neoplasms in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.

Research Excerpts

ExcerptRelevanceReference
"Malignant Leydig cell tumors (LCT) are rare."2.38Treatment of malignant Leydig cell tumor. ( Bertram, KA; Bratloff, B; Davidson, H; Hodges, GF, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertram, KA1
Bratloff, B1
Hodges, GF1
Davidson, H1

Reviews

1 review available for mitotane and Retroperitoneal Neoplasms

ArticleYear
Treatment of malignant Leydig cell tumor.
    Cancer, 1991, Nov-15, Volume: 68, Issue:10

    Topics: Doxorubicin; Humans; Leydig Cell Tumor; Male; Middle Aged; Mitotane; Retroperitoneal Neoplasms; Test

1991